title: AMH levels at central precocious puberty and premature thelarche: is it a parameter?
abstract: BACKGROUND
  The possible difference of antimüllerian hormone (AMH) levels at central precocious puberty (CPP) and premature thelarche (PT) has not been properly evaluated.
  
  
  OBJECTIVE
  By evaluating AMH levels in girls with diagnosed CPP and PT, we aim to show the change of AMH levels at the pubertal onset.
  
  
  METHODS
  Sixty-five girls who have breast development before the age of 8 years and 25 healthy girls were enrolled in the study.
  
  
  METHODS
  The subjects were divided into two groups as CPP and PT, according to results of GnRH test. AMH levels were determined in the two groups.
  
  
  RESULTS
  The mean AMH levels of the CPP group were significantly lower than those in the PT group (13.57±9.85 pmol/L and 58.42±12.78 pmol/L, respectively, p=0.022).
  
  
  CONCLUSIONS
  These results suggest that the AMH levels decrease in the duration of the hypothalamus-pituitary-ovarian axis activation. We thought that AMH might/may be a marker for distinguishing between CPP and PT.
authors.forename: Nursel Muratoglu
authors.initials: NM
authors.lastname: Sahin
authors.forename: Sibel Tulgar
authors.initials: ST
authors.lastname: Kinik
authors.forename: Mustafa Agah
authors.initials: MA
authors.lastname: Tekindal
authors.forename: Nilufer
authors.initials: N
authors.lastname: Bayraktar
mesh_terms: D054304:Anti-Mullerian Hormone / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001940:Breast / Q000254:growth & development; D002648:Child; D002675:Child, Preschool; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D011629:Puberty, Precocious / Q000097:blood*
chemical_list: D015415:Biomarkers; D054304:Anti-Mullerian Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone